☆ 4.7 Article

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Letter Gastroenterology & Hepatology

Global prediction of primary liver cancer incidences and mortality in 2040

Chenxi Li et al.

JOURNAL OF HEPATOLOGY (2023)

Add to Collection

Article Allergy

Airway administration of OM-85, a bacterial lysate, blocks experimental asthma by targeting dendritic cells and the epithelium/IL-33/ILC2 axis

Vadim Pivniouk et al.

Summary: This study demonstrates that direct administration of OM-85 to the airway compartment can protect against experimental allergic asthma by engaging multiple immune pathways. The efficacy of intranasal OM-85 administration may be due to its direct access to the airway mucosal networks controlling the initiation and development of allergic asthma.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of OM-85 in paediatric recurrent respiratory tract infections which could have a possible protective effect on COVID-19 pandemic: A meta-analysis

Changqing Cao et al.

Summary: OM-85 consumption is significantly associated with a lower frequency, total duration, incidence, number of antibiotic courses, and antibiotic use in respiratory tract infections. However, it is not significantly related to adverse events or wheezing attacks frequency. This indicates that OM-85 could be a valuable tool to improve immunity against recurrent respiratory tract infections, especially in critical situations like the COVID-19 pandemic.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection

Myron S. Cohen

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Allergy

Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia

Emanuele Pontali et al.

Summary: The study indicates that early use of high doses of intravenous anakinra, with or without glucocorticoids, may have potential efficacy and safety in treating COVID-19 pneumonia on a larger series of patients.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells

Matthew Mahoney et al.

Summary: A novel TMPRSS2 inhibitor, MM3122, has shown exceptional potency in inhibiting viral entry and reducing cytopathic effects, with promising potential as a treatment for COVID-19. This compound, discovered using SBDD, exhibits unique structural features and excellent pharmacokinetic properties, making it a strong candidate for in vivo efficacy evaluation.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Interleukin-6 Receptor Inhibition in Covid-19-Cooling the Inflammatory Soup

Eric J. Rubin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Immunology

SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

Nikolaos C. Kyriakidis et al.

Summary: The new SARS-CoV-2 virus is rapidly spreading worldwide, causing the COVID-19 pandemic with more than 1.866 million deaths. Over 64 vaccine candidates are being developed globally, aiming to induce antibodies to prevent viral entry. Thirteen vaccine candidates are currently in Phase 3 clinical trials, showing promising progress towards approval for large-scale immunizations.

NPJ VACCINES (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Membrane Nanoparticles Derived from ACE2-Rich Cells Block SARS-CoV-2 Infection

Cheng Wang et al.

Summary: Membrane nanoparticles derived from ACE2-rich cells were found to effectively block SARS-CoV-2 infection by trapping viral ligands and reducing viral recruitment to host cells. These ACE2-NPs also inhibited viral entry into cells and blocked infection, providing a promising avenue for COVID-19 treatment.

ACS NANO (2021)

Add to Collection

Article Immunology

SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2

Qiao Lu et al.

Summary: Multiple C-type lectins and TTYH2 were identified as glycan-dependent binding partners of SARS-CoV-2 spike, predominantly expressed on myeloid cells in the lungs of COVID-19 patients. Engagement of these receptors with the virus induced robust proinflammatory responses, correlating with disease severity. Targeting SARS-CoV-2-myeloid receptor interactions may provide potential therapeutic strategies for COVID-19.

IMMUNITY (2021)

Add to Collection

Article Cell Biology

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2

Mark Dittmar et al.

Summary: There is an urgent need for antiviral drugs to treat SARS-CoV-2, and screening has identified several potential candidates with different mechanisms of action in lung epithelial cells. Some of these drugs could be used for the treatment of respiratory cells in patients.

CELL REPORTS (2021)

Add to Collection

Article Critical Care Medicine

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Sanjay Ramakrishnan et al.

Summary: The study found that early administration of inhaled budesonide reduced the likelihood of needing urgent medical care and accelerated recovery time in patients with early COVID-19.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies

Yafei Liu et al.

Summary: The research found that antibodies against different domains of the SARS-CoV-2 spike protein have different effects, with some antibodies inducing an open conformation of the RBD and enhancing the virus infectivity. Structural and mutational analysis revealed the mechanisms of these antibodies, and infectivity-enhancing antibodies were detected at higher levels in severe patients.

CELL (2021)

Add to Collection

Article Virology

Seroprevalence of SARS-CoV-2 antibodies among rural healthcare workers

Jordan Z. Neises et al.

Summary: This longitudinal cohort study aimed to determine the seroprevalence of SARS-CoV-2 antibodies in healthcare workers in rural areas of South Dakota and Minnesota. The study found varying seroprevalence rates over different time periods and identified individuals with no history of COVID-19 diagnosis. A high percentage (85%) of seronegative individuals was observed in the study population by December 2020.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

M. Dougan et al.

Summary: In this phase 3 trial, the combination of bamlanivimab plus etesevimab was found to reduce the incidence of Covid-19-related hospitalization and death among high-risk ambulatory patients compared to placebo, and also accelerated the decline in SARS-CoV-2 viral load.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia

Patricia O. Guimaraes et al.

Summary: Among patients hospitalized with Covid-19 pneumonia, tofacitinib led to a lower risk of death or respiratory failure through day 28 than placebo. The mortality rate was lower in the tofacitinib group within 28 days. However, the rate of serious adverse events was similar in both groups.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 Variants and Vaccines

Philip R. Krause et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

Nir Drayman et al.

Summary: This study identified a drug called masitinib that can inhibit the replication of both SARS-CoV-2 and OC43 virus, and acts by competitively inhibiting 3CLpro. The drug showed strong antiviral effects in in vivo experiments on mice infected with SARS-CoV-2, and was effective against multiple variants in vitro.

SCIENCE (2021)

Add to Collection

Article Virology

Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms

Chuan Xu et al.

Summary: This study utilized a simple, two-plasmid pseudotyped virus system to investigate the entry event of SARS-CoV-2 in various cell lines. Pseudotyped SARS-CoV-2 viruses produced under serum-free conditions were able to infect a broader range of cells, including those without hACE2 overexpression.

VIRUSES-BASEL (2021)

Add to Collection

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Add to Collection

Article Microbiology

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Alexander E. Gorbalenya et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

Yixuan J. Hou et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Carly G. K. Ziegler et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

Add to Collection

Article Gastroenterology & Hepatology

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis

Ka Shing Cheung et al.

GASTROENTEROLOGY (2020)

Add to Collection

Article Allergy

Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells

Hiroki Kimura et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Virology

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

Katharine H. D. Crawford et al.

VIRUSES-BASEL (2020)

Add to Collection

Article Multidisciplinary Sciences

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

David E. Gordon et al.

NATURE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Waradon Sungnak et al.

NATURE MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Multiorgan and Renal Tropism of SARS-CoV-2

Victor G. Puelles et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of SARS-CoV-2 by type I and type III interferons

Ulrike Felgenhauer et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Bacterial Lysates as Immunotherapies for Respiratory Infections: Methods of Preparation

Norma Suarez et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

Laura Riva et al.

NATURE (2020)

Add to Collection

Review Immunology

Animal and translational models of SARS-CoV-2 infection and COVID-19

M. D. Johansen et al.

MUCOSAL IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

Add to Collection

Review Allergy

Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions

Desiree Larenas-Linnemann et al.

WORLD ALLERGY ORGANIZATION JOURNAL (2020)

Add to Collection

Correction Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein (vol 180, 281.e1, 2020)

Alexandra C. Walls et al.

CELL (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Drug repurposing: progress, challenges and recommendations

Sudeep Pushpakom et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Add to Collection

Review Allergy

Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence

Susanna Esposito et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP

Michael Roth et al.

PLOS ONE (2017)

Add to Collection

Article Biotechnology & Applied Microbiology

Normalization of RNA-seq data using factor analysis of control genes or samples

Davide Risso et al.

NATURE BIOTECHNOLOGY (2014)

Add to Collection

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Add to Collection

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

Add to Collection

Article Respiratory System

Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma

M. Kraft et al.

EUROPEAN RESPIRATORY JOURNAL (2008)

Add to Collection

Article Critical Care Medicine

Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract -: A double-blind, placebo-controlled multicenter study

UB Schaad et al.

CHEST (2002)

Add to Collection

Article Biochemistry & Molecular Biology

Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods

L Sastry et al.

GENE THERAPY (2002)

Add to Collection

Article Biochemical Research Methods

Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method

KJ Livak et al.

METHODS (2001)

Add to Collection

Article Critical Care Medicine

Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months

MD Gutiérrez-Tarango et al.

CHEST (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.